Markets:

Overview

News

Currencies

International

Treasuries

Annovis Bio, Inc. Common Stock (NY:ANVS)

1.840 -0.010 (-0.54%)

Official Closing Price Updated: 7:00 PM EDT, Apr 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Annovis Bio, Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

17 18 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 27, 2023

Via Benzinga

Dear PSNY Stock Fans, Mark Your Calendars for Oct. 12 ↗

October 06, 2022

Fans of Polestar Automotive (PSNY) stock will want to keep an eye on the company as a potential catalyst is coming on Oct. 12.

Via InvestorPlace

Why Is Annovis Bio (ANVS) Stock Up 12% Today? ↗

October 06, 2022

Annovis Bio (ANVS) stock is getting a boost on Thursday following news that the company will proceed with its Alzheimer's clinical trial.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 06, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.

Via Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗

September 28, 2022

Via Benzinga

FDA Gives Green Signal To Annovis Bio's Parkinson's Trial With Buntanetap ↗

July 07, 2022

Via Benzinga

Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday ↗

September 21, 2022

Gainers

Via Benzinga

Stocks Deepen Losses As Treasury Yields Soar ↗

September 20, 2022

The Dow Jones Industrial Average is deepening this morning's losses, down nearly 320 points at last check, as the Federal Open Market Committee's (FOMC) two-day policy meeting gets underway.

Via Talk Markets

S&P 500 Down 0.6%; Crude Oil Falls Sharply ↗

September 15, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 15, 2022

Via Benzinga

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 12, 2022

Via Benzinga

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session ↗

September 09, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 09, 2022

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 24, 2022

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off ↗

August 24, 2022

Annovis Bio, Inc. (NYSE: ANVS) has initiated patient dosing in the Phase 3 clinical trial evaluating buntanetap in early Parkinson's Disease (PD). The Phase 3 trial is designed to evaluate the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗

September 08, 2022

Via Benzinga

Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron ↗

August 02, 2022

Recent publishing of Longeveron Inc.’s (NASDAQ: LGVN)

Via Benzinga

Dear AMC Stock Fans, Mark Your Calendars for Aug. 4 ↗

July 07, 2022

AMC Entertainment (AMC) stock is in the news today as investors in the theater company prepare for a potential catalyst coming next month!

Via InvestorPlace

Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update ↗

July 07, 2022

Annovis Bio (ANVS) stock is soaring higher on Thursday following a positive update from the FDA for its buntanetap clinical trial.

Via InvestorPlace

Annovis Bio Gets FDA Nod For Late-Stage Parkinson Disease Study Amendments ↗

July 07, 2022

The United States Food and Drug Administration (FDA) announced clearance for amendments to Annovis Bio’s (NYSE: ANVS) Phase 3 clinical study of Buntanetap for the treatment of Parkinson's disease.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 07, 2022

Via Benzinga

Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update

May 04, 2022

Berwyn, Pennsylvania--(Newsfile Corp. - May 4, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug...

Via Newsfile

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

June 08, 2022

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022 ↗

May 02, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid ↗

April 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging

April 28, 2022

Berwyn, Pennsylvania--(Newsfile Corp. - April 28, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug...

Via Newsfile

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Annovis Bio, Inc. Common Stock (NY:ANVS)

All News about Annovis Bio, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today